Antoni Camins

17.0k total citations · 2 hit papers
318 papers, 13.5k citations indexed

About

Antoni Camins is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Antoni Camins has authored 318 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Molecular Biology, 123 papers in Physiology and 99 papers in Cellular and Molecular Neuroscience. Recurrent topics in Antoni Camins's work include Alzheimer's disease research and treatments (76 papers), Neuroscience and Neuropharmacology Research (76 papers) and Neuroinflammation and Neurodegeneration Mechanisms (34 papers). Antoni Camins is often cited by papers focused on Alzheimer's disease research and treatments (76 papers), Neuroscience and Neuropharmacology Research (76 papers) and Neuroinflammation and Neurodegeneration Mechanisms (34 papers). Antoni Camins collaborates with scholars based in Spain, Mexico and Chile. Antoni Camins's co-authors include Mercè Pallàs, Jaume Folch, Miren Ettcheto, Ester Verdaguer, Elena Sánchez‐López, María L. García, Anna M. Canudas, Amanda Cano, Gemma Casadesús and Carme Auladell and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Lancet Neurology.

In The Last Decade

Antoni Camins

316 papers receiving 13.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metal-Based Nanoparticles as Antimicrobial Agents: An Overview

2020 1.0k citations Elena Sánchez‐López, Gerard Esteruelas et al. Nanomaterials profile →
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

2019 247 citations Amanda Cano, Miren Ettcheto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antoni Camins Spain	63	4.8k	4.1k	2.5k	1.8k	1.5k	318	13.5k
Gianluigi Forloni Italy	68	7.8k 1.6×	5.8k 1.4×	3.3k 1.3×	4.0k 2.2×	1.3k 0.9×	368	16.0k
Paula I. Moreira Portugal	72	7.7k 1.6×	7.3k 1.8×	1.9k 0.8×	2.0k 1.1×	2.0k 1.3×	236	17.2k
Vittorio Calabrese Italy	84	8.3k 1.7×	5.3k 1.3×	1.6k 0.6×	2.0k 1.1×	1.7k 1.2×	294	18.5k
Andrey Y. Abramov United Kingdom	73	9.3k 1.9×	5.3k 1.3×	3.3k 1.3×	2.4k 1.3×	937 0.6×	208	17.9k
David T. Dexter United Kingdom	58	5.7k 1.2×	3.2k 0.8×	5.1k 2.0×	3.2k 1.8×	795 0.5×	136	16.4k
Grace Y. Sun United States	67	5.8k 1.2×	3.4k 0.8×	2.5k 1.0×	2.5k 1.4×	837 0.6×	341	14.3k
Inhee Mook‐Jung South Korea	64	4.6k 1.0×	4.9k 1.2×	1.7k 0.7×	2.4k 1.3×	1.1k 0.8×	208	11.3k
Gjumrakch Aliev Russia	58	5.7k 1.2×	5.5k 1.4×	1.4k 0.6×	1.9k 1.0×	1.8k 1.2×	284	13.2k
Weidong Le China	71	6.2k 1.3×	3.3k 0.8×	5.1k 2.0×	3.4k 1.9×	1.0k 0.7×	289	17.2k
D. Allan Butterfield United States	88	11.1k 2.3×	10.2k 2.5×	2.5k 1.0×	2.7k 1.5×	2.8k 1.9×	285	24.2k

Countries citing papers authored by Antoni Camins

Since Specialization

Citations

This map shows the geographic impact of Antoni Camins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoni Camins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoni Camins more than expected).

Fields of papers citing papers by Antoni Camins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoni Camins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoni Camins. The network helps show where Antoni Camins may publish in the future.

Co-authorship network of co-authors of Antoni Camins

This figure shows the co-authorship network connecting the top 25 collaborators of Antoni Camins. A scholar is included among the top collaborators of Antoni Camins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoni Camins. Antoni Camins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bicker, Joana, Ana Silva, Armanda E. Santos, et al.. (2025). Protective effects of irbesartan against neurodegeneration in APP/PS1 mice: Unraveling its triple anti-apoptotic, anti-inflammatory and anti-oxidant action. Biomedicine & Pharmacotherapy. 188. 118167–118167. 1 indexed citations

Rabanal, Francesc, Ana M. Marqués, Elena Sánchez‐López, et al.. (2025). B-rich colistin and B-pure colistin as novel strategies to increase the therapeutic window of polymyxin antibiotic therapy. Biomedicine & Pharmacotherapy. 190. 118366–118366.

Olloquequi, Jordi, Roberto Díaz‐Peña, Ester Verdaguer, et al.. (2024). From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer’s Disease. International Journal of Molecular Sciences. 25(13). 6928–6928. 14 indexed citations

Barroso, Emma, Ricardo Rodríguez‐Calvo, Antoni Camins, et al.. (2024). PPARβ/δ upregulates the insulin receptor β subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels. Cell Communication and Signaling. 22(1). 595–595. 1 indexed citations

Camins, Antoni, et al.. (2024). Intranasal irbesartan reverts cognitive decline and activates the PI3K/AKT pathway in an LPS-induced neuroinflammation mice model. International Immunopharmacology. 128. 111471–111471. 9 indexed citations

Olloquequi, Jordi, Miren Ettcheto, Amanda Cano, et al.. (2023). Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment. International Journal of Molecular Sciences. 24(18). 14177–14177. 12 indexed citations

Antequera, Desireé, Lara Ordóñez‐Gutiérrez, Francisco Wandosell, et al.. (2022). Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models. Scientific Reports. 12(1). 10092–10092. 56 indexed citations

Cano, Amanda, Miren Ettcheto, Marta Espina, et al.. (2021). Epigallocatechin-3-Gallate PEGylated Poly(Lactic-Co-Glycolic) Acid Nanoparticles Mitigate Striatal Pathology and Motor Deficits in 3-Nitropropionic Acid Intoxicated Mice. Nanomedicine. 16(1). 19–35. 25 indexed citations

Cano, Amanda, Miren Ettcheto, Eliana B. Souto, et al.. (2021). Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease. Applied Sciences. 11(9). 4305–4305. 41 indexed citations

10.

Bonilla, Lorena, Marta Espina, Patrícia Severino, et al.. (2021). Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics. 14(1). 90–90. 54 indexed citations

11.

Ettcheto, Miren, Amanda Cano, Elena Sánchez‐López, et al.. (2021). Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment. Pharmaceuticals. 14(9). 890–890. 33 indexed citations

12.

Sánchez‐López, Elena, Gerard Esteruelas, A. Ortiz, et al.. (2020). Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study. Nanomaterials. 10(4). 720–720. 60 indexed citations

13.

Ettcheto, Miren, et al.. (2020). A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease. Current Pharmaceutical Design. 26(12). 1286–1299. 11 indexed citations

14.

Sánchez‐López, Elena, João Dias-Ferreira, Ana López-Machado, et al.. (2019). Current Applications of Nanoemulsions in Cancer Therapeutics. Nanomaterials. 9(6). 821–821. 178 indexed citations

15.

Souto, Eliana B., João Dias-Ferreira, Ana López-Machado, et al.. (2019). Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents. Pharmaceutics. 11(9). 460–460. 140 indexed citations

16.

Busquets, Oriol, Miren Ettcheto, Amanda Cano, et al.. (2019). Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment. International Journal of Molecular Sciences. 21(1). 255–255. 22 indexed citations

17.

Abad, Sònia, Raúl López‐Arnau, Jaume Folch, et al.. (2019). Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice. Journal of Psychopharmacology. 33(9). 1170–1182. 8 indexed citations

18.

Abad, Sònia, Jorge Camarasa, David Pubill, Antoni Camins, & Elena Escubedo. (2015). Adaptive Plasticity in the Hippocampus of Young Mice Intermittently Exposed to MDMA Could Be the Origin of Memory Deficits. Molecular Neurobiology. 53(10). 7271–7283. 20 indexed citations

19.

Bayod, Sergi, Jaume del Valle, Carme Pelegrı́, et al.. (2014). Macroautophagic process was differentially modulated by long-term moderate exercise in rat brain and peripheral tissues.. PubMed. 65(2). 229–39. 31 indexed citations

20.

Pelegrı́, Carme, Joaquim Duran‐Vilaregut, Jaume del Valle, et al.. (2008). Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3‐nitropropionic acid. International Journal of Developmental Neuroscience. 26(7). 665–671. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact